Hydrochlorothiazide Tablet
Product Images NDC 51655-088

2 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 51655-088). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (Molecule)

Molecular Structure (Molecule)
Chemical structure of Hydrochlorothiazide showing its molecular arrangement with a benzothiadiazine ring system including a sulfonamide group and hydroxyl substitution.*
FDA Label Image

Label (51655 088 52 Rev A 03 23 Nhc)

Label (51655 088 52   Rev A 03 23 Nhc)
Label for Hydrochlorothiazide Tablets USP 25 mg, containing 30 tablets. The product is labeled for prescription use only (Rx Only) and includes storage instructions directing to see the package insert and to store at 20°-25°C (68°-77°F). It is manufactured or labeled by Northwind Health Company, LLC. The label includes the NDC 51655-088-52 and advises keeping the product out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.